DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
O'Reilly EM, Oh D-Y, Dhani N. et al.
Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial.
JAMA Oncol 2019;
5 (10) 1431-1438
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.